ロイタービデオ

次のビジネス (26 ビデオ)

    ビジネス

    Pfizer, BioNTech start testing Omicron vaccine

    Pfizer and BioNTech said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen. Fred Katayama reports.